ExSURE PVT. LTD.
EXSURE is an R & D-based startup and we are developing the next generation of exosome-based cancer therapeutics. We are developing a unique exosome-based chemotherapeutic drug-delivery platform that will facilitate precise and guided delivery of anti-cancer drugs (existing on the market) into tumor cells and relapse-causing cells (cancer stem cells) without abruptly harming the healthy cells. Our platform will reduce chemotoxicity and chances of cancer relapse in cancer patients. Currently, we are working with a breast cancer model. We have validated the efficiency and efficacy of our platform in vitro (in different breast cancer cell lines and derived cancer stem cells) and ex-vivo (primary cells & stem cells derived from chemo-naive clinical samples of breast tumor biopsies). We are yet to validate our platform in vivo (SCID mice). We have filed the patent for the formulation we are using to develop these bioengineered drug-loaded targeted exosomes and the methodology behind it (Final patent to be filed this month). We are providing outsourcing services including any type of cell-culture-based assays, exosome-based experimentations, and cancer stem cell-based assays.
ExSURE PVT. LTD.
Exsure is an R&D-focused Indian biotech startup pioneering exosome-based targeted drug delivery platforms for cancer treatment.
About
Needs Assessment
Active buying signals and potential business opportunities
Technology Requirements
Exosome isolation reagents
Lymphocyte separation reagents
Reagents and kits for exosome isolation, lymphocyte separation, and lipid quantification.
Exosome engineering tools
Exosome isolation and engineering technologies.
Drug delivery systems
Diagnostic assays
Exosome isolation and characterization technologies.
PBMC isolation reagents
Reagents for exosome modification and drug loading
Service Requirements
Grant writing support and guidance
Research and development in exosome-based applications.
Science & Service
Book Exosure
Cancer-stem cell based Outsourcing services
Exosome-based Outsourcing services
Isolation of exosomes from various sources
Characterization of exosomes isolated from various sources.
Generation of bioengineered targeted exosomes and drug delivery.
Exosome isolation and characterization services
Drug loading services
Custom exosome engineering services
Infrastructure Requirements
Cell culture facilities
Bioengineering equipment
Plate reader
Cell culture facilities, bioengineering equipment.
Laboratory equipment for cell culture and exosome analysis
Cell culture facilities, exosome isolation and characterization equipment, drug loading systems.
Molecular biology laboratories.
Molecular biology labs
Talent Requirements
Expertise in exosome biology, cancer stem cell targeting, and nano drug delivery.
Scientific staff to support exosome isolation, characterization, and engineering.
Research and development scientists focused on exosome-based therapeutics.
Professionals with experience in regulatory compliance and clinical trials.
Team scaling needs
Experience in glycoengineering
AI Insights
Growth Trajectory
Exsure secured a seed fund of ₹3 Cr from Unicorn India and is actively developing new products, indicating strong growth potential in the biotechnology sector.
Market Opportunity
Exsure's first patented exosome-based platform in India provides a significant competitive advantage in the growing market for targeted cancer therapies, positioning them for market expansion and innovation.
Access Our Live VC Funding Database
30,000+ funded startups
tracked in the last 3 months
B2B verified emails
of key decision makers
Growth metrics
Real-time company performance data
Live updates
of new VC funding rounds
Advanced filters
for sophisticated queries
API access
with multiple export formats